| dc.description | Tobacco smoking has long been considered a risk factor for periodontal disease development owing to the components of tobacco such as nicotine. However cannabis has been shown in recent years to play comparable functions in the development of disease. With marijuana use increasing across all sociodemographic categories, periodontal complications may pose a significant and growing oral health concern. Although cannabis is classed as a non-addictive substance with a danger level comparable to coffee or cigarettes, current research indicates that long-term use can result in harmful side effects such as interfering with the pathophysiology of bone and perhaps possessing immunosuppressive qualities. Therefore, the purpose of this study was to conduct a bibliographic review providing available evidence to investigate the recreational use of cannabis as a risk factor for periodontal disease. The study also included an analysis of the drug's probable mechanism of action, its effect on periodontal tissues, and the age range most affected by the drug's usage. This study used publications containing relevant information in languages such as English , Portuguese and Spanish published over the last 15 years as well as researches conducted on people and animals . Databases searched were PubMed, Google Scholar, Scielo, and Scopus. In the end, the study indicated that recreational cannabis use may soon be linked to periodontal disease, alongside cigarette use. This is because the drug's mechanism may impact the immune response and reduce periodontal tissue's ability to heal following disease activity, and this may be dosage dependant. It is also thought to aggravate the condition by causing alveolar bone loss and disrupting the microbial dysbiosis. Due to the drug's short-term exposure, these traits are likely to be exhibited in adults and elders. [resumo fornecido pelo autor] | pt_BR |
